NCT03854409View on ClinicalTrials.gov

A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

April 5, 2019

Study Completion Date

February 20, 2020

Conditions
SchizophreniaBipolar I Disorder
Interventions
DRUG

Aripiprazole

Injection.

Trial Locations (4)

72211

Woodland International Research Group, Little Rock

78754

Community Clinical Research, Austin

92845

Collaborative Neuroscience Network, Garden Grove

08009

Hassman Research Institute, Berlin

Sponsors

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

collaborator

H. Lundbeck A/S

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT03854409 - A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder | Biotech Hunter | Biotech Hunter